AzTrials
AzTrials

Decayed TeethNCT05465421

Effect of Bone Marrow Mononuclear Cell Layer Seeded on Platelet-rich Fibrin on an Alveolar Socket After Extraction

A study testing bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation in people with Decayed Teeth, run by Cairo University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Bone marrow aspiration from maxillary tuberosity will be centrifuged to separate the bone marrow mononuclear cell layer using the density gradient separation method, then it will be seeded in a platelet-rich fibrin membrane and used for socket preservation to test the osteogenic ability of the bone marrow mononuclear… Read more about this study

Who is it for?
Ages 22 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Decayed Teeth
What is being tested?
bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteEgypt
Study dates
1 May 2022to 1 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 22 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Patients with badly decayed tooth indicated for extraction
  • Patients with healthy systemic condition (Medically free)
  • Adequate inter-arch space for placement of the implant prosthetic part.
  • Good oral hygiene
  • Cooperative patients who are willing to commit for 6 months follow up

Who cannot join

  • Smokers
  • Pregnant females
  • Patient with medical condition that contraindicates surgical procedures
  • Patients on medication that may interfere with healing (corticosteroids, bisphosphonate, Chemo/radio therapy).
  • Patients with habits that may jeopardize the implant longevity and affect the results of the study such as alcoholism or parafunctional habits.

Trial locations and contacts

1 site in 1 country.

Egypt1 site, 1 recruiting
  • Cairo University

    Cairo

    02 35676105

    hani elnahass

    Recruiting

Other trials in Egypt

About this study

Official title: Clinical and Radiographic Assessment of Buccolingual Bone Dimension Following Socket Preservation With Bone Marrow Mono-nuclear Cell From the Maxillary Tuberosity Combined With Platelet-rich Fibrin Compared With Platelet-rich Fibrin Alone

Bone marrow aspiration from maxillary tuberosity will be centrifuged to separate the bone marrow mononuclear cell layer using the density gradient separation method, then it will be seeded in a platelet-rich fibrin membrane and used for socket preservation to test the osteogenic ability of the bone marrow mononuclear cell layer in comparison to platelet-rich fibrin alone both ways will receive implant after 3 months

Read the detailed description

-Research question: In patients with teeth requiring extraction will bone marrow mononuclear cell layer (BMMNC) from maxillary tuberosity seeded on platelet-rich fibrin (PRF) maintain the bucco-palatal/lingual bone dimension during socket preservation compared to platelet rich fibrin alone?

-The rationale for conducting the research: Bone marrow is full of progenitors and cell markers that promote tissue healing. Traditionally bone marrow aspiration is done from extra-oral sites. The obstacle in extra-oral aspiration is the site morbidity and the need to put the patient under general anesthesia.

Intraoral sites like the maxillary tuberosity are filled with marrow spaces that can facilitate the harvesting of marrow cells and reduce the trauma of the harvesting process.

Bone marrow mononuclear cell (BMMNC) transplantation may result in higher rates of bone marrow regeneration in the extraction socket and significantly accelerate bone maturation. It is also suggested that Bone marrow mononuclear cell (BMMNC) plays an important role in bone homeostasis within the extraction socket However, Bone marrow mononuclear cell (BMMNC) has several drawbacks that should be taken into consideration like potential pain during harvest, and variable stem cell quantity and quality depending on age which may hinder the usage of Bone marrow mononuclear cell (BMMNC) in old ages.

The bone regeneration ability of that population of cells and the ease of their acquisition render them good candidates for socket preservation. Hence, the current study aims to evaluate the use of Bone marrow mononuclear cells (BMMNC) obtained from the maxillary tuberosity in promoting bone formation in the alveolar socket after extraction.

-The explanation for the choice of comparators: A parallel group of 12 patients with a non-restorable tooth will undergo extraction and socket preservation.

  • In group 1: socket preservation will be done by PRF PRF membrane used in the extraction sockets was demonstrated to promote local soft tissue healing of gums and reduce postoperative pain response. While the effect of PRF to reduce alveolar bone resorption was not significant, PRF was able to increase the quality of the novel bone and enhance the rate of bone formation due to the concentration of growth factors
  • In group 2: sock preservation will be done by Bone marrow mononuclear cell (BMMNC) from the maxillary tuberosity on PRF

In the current study, the density gradient separation method technique will be used to harvest BMMNC. This method has been used to enrich the isolated mononuclear cell fraction and has been an essential part of several clinical procedures. The density gradient separation/immediate transplantation method is superior to the in vitro expansion method as the cells are minimally manipulated; there is no invasive enzymatic treatment used. This method allows immediate autologous transplantation of BMAC that minimizes the risk of contamination by decreasing the time of cell handling in cell culture

-Objectives: The objective of the study is to find out the osteogenic potential of BMMNC from the maxillary tuberosity in comparison with PRF alone in socket preservation for delayed implant placement

-Trial design:

The current study will be designed as a:

  • Parallel 2 arm
  • Randomized Controlled Clinical Trial,
  • Allocation ratio 1:1
  • Superiority Trial
  • Methods . Interventions
  • Preoperative evaluation:
  • Clinical examination \& informed consent:

Evaluation of the patient's general condition of the oral cavity, to make sure it complies with the criteria required to be enrolled in the study in terms of oral hygiene, pathological conditions

-Radiographic examination:

Cone beam CT will be taken before proceeding with any procedure to make sure of the restorability of the tooth before extraction, checking for any radiolucency to be removed also to measure bone width before extraction

  • Surgical procedures:
  • Local anesthesia will be administered by infiltration or nerve block to achieve the necessary anesthesia to allow extraction of the indicated tooth
  • Extraction will be done as atraumatically as possible removing any pathosis found that may interfere with bone formation
  • Allocation concealment will be broken and socket preservation will be done In group 1
  • A trapezoidal flap will be created above the extraction socket to allow closure of the surgical site.
  • PRF will be placed in the socket
  • The flap will be closed by interrupted sutures using 5-0 sutures. In group 2 (test group)
  • A trapezoidal flap will be created above the extraction socket to allow closure of the surgical site.
  • BMMNC will be seeded on platelet-rich fibrin and inserted into the socket
  • The flap will be closed by interrupted sutures using 5-0 sutures.

BMMNCs aspiration and centrifugation technique:

  • Under the supervision of professor: Hani el Nahass and doctor: Omnia k Tawfik A 20 gauge needle will be inserted in the maxillary tuberosity area through the palatal aspect until aspiration is positive
  • Aspirate will be collected in a heparin-treated tube (2000:1) using 1ml of anticoagulant citrate dextrose solution (ACD-A) for every 15ml of bone marrow aspiration.
  • Aspirate will be centrifuged to separate the BMMNCs using the density gradient separation method.
  • Ficoll® Paque Plus (GE Healthcare, Buckinghamshire, UK) bottle will be inverted several times to ensure thorough mixing and 3 ml of the media will be added to a centrifuge tube
  • The bone marrow aspirate will be diluted (1:1) with saline and then carefully layered onto the Ficoll gradient and then centrifuged at 2000 rpm for 20 min at room temperature using a multi-speed 4000 rpm vertical rotor.
  • The upper layer containing plasma and platelets will be collected using a sterile pipette, leaving the mononuclear cell layer undisturbed at the interface. The layer of mononuclear cells will be transferred to a sterile centrifuge tube using a sterile pipette.
  • Postsurgical procedure (three months after socket preservation)
  • Local anesthesia will be administered by infiltration or nerve block to achieve the necessary anesthesia
  • A flap will be raised at the site of the extracted tooth
  • A core biopsy will be harvested by introducing a core drill bit in place of an initial drill
  • Sequential drilling will take place to prepare osteotomy to the right size to receive an implant
  • Implant will be placed in the osteotomy with the platform flush with the bone
  • Flap closure will be achieved by interrupted 5-0 sutures

Histologic processing:

The harvested bone biopsies will be decalcified in ethylene diamine tetra acetic acid (10%) for two weeks. After dehydration in graded series of ethanol, the specimens will be embedded in paraffin and sectioned by a high-speed rotating blade microtome; the sections will be stained with hematoxylin-eosin stain. This will be followed by histomorphometric analysis using the Leica Qwin 500 (Leica microsystems Inc., Switzerland) image analyzer computer system (England). Area percentage (%) of newly formed bone will be calculated

Quantitative real-time polymerase chain reaction (qRT-PCR)

real-time polymerase chain reaction(RT-PCR) will be used to analyze the massenger Ribonucleic acid (mRNA) levels of alkaline phosphatase

  • Postoperative instructions and follow-up:

Administration of:

  • Antibiotics (Amoxicillin 1g twice daily for 5 days) to prevent any chance of infection. (Eugenio Romeo et al, 2014).
  • Anti-inflammatory drugs (NSAIDS; Ibuprofen 600mg three times daily for 5 days) to avoid any chance of edema or pain or swelling
  • Antiseptic mouth rinse (0.12% Chlorhexidine oral rinse will be prescribed for 60 seconds two times a day for 14 days.
  • The patient will be instructed to follow up for the next 3 months before implant placement

Patient self-care instructions:

  • Application of an ice bag to the treated area for the first 24 hours.
  • Avoid any brushing and trauma to the surgical site for one week.
  • Avoid smoking
  • Outcomes:

PICO:(population-intervention-compatetor-outcome) P: Patients with non-restorable teeth indicated for extraction I: BMMNC from the tuberosity for socket preservation C: Platelet rich fibrin O: Bucco-palatal/lingual bone dimension Prioritization of Outcome Outcome Method of Measurement Unit of Measurement Primary outcome

Secondary objectives To calculate the postoperative pain, patient satisfaction and Alkaline phosphatase measurement in a histological sample of the newly formed bone took 3 months later before implant placement

Conditions
Decayed Teeth
Being tested
bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservationOther

    Local anaesthesia will be administered by infiltration or nerve block to achieve the necessary anaesthesia to allow extraction of the indicated tooth Extraction will be done as atraumatically as possible removing any pathosis found that may interfere with bone formation A trapezoidal flap will be created above the extraction socket to allow closure of the surgical site.

    BMMNC will be seeded on platelet rich fibrin and inserted in the socket The flap will be closed by interrupted sutures using 5-0 sutures. implant placement 3 months later

Study groups in NCT05465421
Study groupRoleWhat they receive
socket preservation with platelet rich fibrin PRF alone the implant placement 3 months afterActive comparatorafter extraction socket preservation will be done by using PRF only in the socket and closed the socket by flap advancement.
Receives: Other: bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation
socket preservation with BMMNCs of bone marrow aspirated of maxillary tuberosityExperimentalafter extraction socket preservation will be done by using bone marrow mononuclear cell layer seeded on PRF in the socket and close the socket by flap advancement
Receives: Other: bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bucco-palatal width of the alveolar socket after extraction with millimeter by cone-beam computed tomography (CBCT)

    The bucco-palatal width of the alveolar socket after extraction will be measured in millimeter using On Demand software at distinct level (2 , 4, and 6mm from the cerst) at the time of extraction and 3 months later after socket preservation with cone-beam computed tomography (CBCT)

    Measured: 3 months after extraction and socket preservation

Secondary outcomes (1)
  1. postoperative pain

    postoperative pain after the surgery, Visual analogue score from (1 to 10) and 10 is the worst pain

    -A patient is asked to indicate his/her perceived pain intensity (most commonly) along a 100 mm horizontal line, and this rating is then measured from the left edge

    Measured: 14 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Jul 2022
  2. Study start1 May 2022
  3. Primary completion1 May 2023 (estimated)
  4. Study completion1 May 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Outcomes assessor
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05465421
Sponsor's protocol ID
cairoU21677
Status last verified
Jul 2022
First submitted
29 Jun 2022
Last updated
29 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Sauerbier S, Rickert D, Gutwald R, Nagursky H, Oshima T, Xavier SP, Christmann J, Kurz P, Menne D, Vissink A, Raghoebar G, Schmelzeisen R, Wagner W, Koch FP. Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial--per-protocol analysis. Tissue Eng Part A. 2011 Sep;17(17-18):2187-97. doi: 10.1089/ten.TEA.2010.0516. Epub 2011 Jun 24.

    PubMed 21529247
  • Pasquali PJ, Teixeira ML, de Oliveira TA, de Macedo LG, Aloise AC, Pelegrine AA. Maxillary Sinus Augmentation Combining Bio-Oss with the Bone Marrow Aspirate Concentrate: A Histomorphometric Study in Humans. Int J Biomater. 2015;2015:121286. doi: 10.1155/2015/121286. Epub 2015 Oct 12.

    PubMed 26543482
  • Wildburger A, Payer M, Jakse N, Strunk D, Etchard-Liechtenstein N, Sauerbier S. Impact of autogenous concentrated bone marrow aspirate on bone regeneration after sinus floor augmentation with a bovine bone substitute--a split-mouth pilot study. Clin Oral Implants Res. 2014 Oct;25(10):1175-81. doi: 10.1111/clr.12228. Epub 2013 Jul 22.

    PubMed 23875876
  • Sauerbier S, Stricker A, Kuschnierz J, Buhler F, Oshima T, Xavier SP, Schmelzeisen R, Gutwald R. In vivo comparison of hard tissue regeneration with human mesenchymal stem cells processed with either the FICOLL method or the BMAC method. Tissue Eng Part C Methods. 2010 Apr;16(2):215-23. doi: 10.1089/ten.TEC.2009.0269.

    PubMed 19473102
  • Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997 Nov;79(11):1699-709. doi: 10.2106/00004623-199711000-00012.

    PubMed 9384430
  • Sununliganon L, Peng L, Singhatanadgit W, Cheung LK. Osteogenic efficacy of bone marrow concentrate in rabbit maxillary sinus grafting. J Craniomaxillofac Surg. 2014 Dec;42(8):1753-65. doi: 10.1016/j.jcms.2014.06.011. Epub 2014 Jun 14.

    PubMed 25052732
  • Duttenhoefer F, Hieber SF, Stricker A, Schmelzeisen R, Gutwald R, Sauerbier S. Follow-up of implant survival comparing ficoll and bone marrow aspirate concentrate methods for hard tissue regeneration with mesenchymal stem cells in humans. Biores Open Access. 2014 Apr 1;3(2):75-6. doi: 10.1089/biores.2014.0003.

    PubMed 24804168
  • de Oliveira TA, Aloise AC, Orosz JE, de Mello E Oliveira R, de Carvalho P, Pelegrine AA. Double Centrifugation Versus Single Centrifugation of Bone Marrow Aspirate Concentrate in Sinus Floor Elevation: A Pilot Study. Int J Oral Maxillofac Implants. 2016 Jan-Feb;31(1):216-22. doi: 10.11607/jomi.4170.

    PubMed 26800181
  • Gapski R, Satheesh K, Cobb CM. Histomorphometric analysis of bone density in the maxillary tuberosity of cadavers: a pilot study. J Periodontol. 2006 Jun;77(6):1085-90. doi: 10.1902/jop.2006.050118.

    PubMed 16734586
  • Al-Ahmady HH, Abd Elazeem AF, Bellah Ahmed NE, Shawkat WM, Elmasry M, Abdelrahman MA, Abderazik MA. Combining autologous bone marrow mononuclear cells seeded on collagen sponge with Nano Hydroxyapatite, and platelet-rich fibrin: Reporting a novel strategy for alveolar cleft bone regeneration. J Craniomaxillofac Surg. 2018 Sep;46(9):1593-1600. doi: 10.1016/j.jcms.2018.05.049. Epub 2018 Jun 2.

    PubMed 30196860
  • Araujo MG, Lindhe J. Dimensional ridge alterations following tooth extraction. An experimental study in the dog. J Clin Periodontol. 2005 Feb;32(2):212-8. doi: 10.1111/j.1600-051X.2005.00642.x.

    PubMed 15691354
  • Zhang Y, Ruan Z, Shen M, Tan L, Huang W, Wang L, Huang Y. Clinical effect of platelet-rich fibrin on the preservation of the alveolar ridge following tooth extraction. Exp Ther Med. 2018 Mar;15(3):2277-2286. doi: 10.3892/etm.2018.5696. Epub 2018 Jan 4.

    PubMed 29456635
  • Mashimo T, Sato Y, Akita D, Toriumi T, Namaki S, Matsuzaki Y, Yonehara Y, Honda M. Bone marrow-derived mesenchymal stem cells enhance bone marrow regeneration in dental extraction sockets. J Oral Sci. 2019;61(2):284-293. doi: 10.2334/josnusd.18-0143.

    PubMed 31217377
  • Marx RE, Tursun R. A qualitative and quantitative analysis of autologous human multipotent adult stem cells derived from three anatomic areas by marrow aspiration: tibia, anterior ilium, and posterior ilium. Int J Oral Maxillofac Implants. 2013 Sep-Oct;28(5):e290-4. doi: 10.11607/jomi.te10.

    PubMed 24066346
  • Iorio-Siciliano V, Blasi A, Nicolo M, Iorio-Siciliano A, Riccitiello F, Ramaglia L. Clinical Outcomes of Socket Preservation Using Bovine-Derived Xenograft Collagen and Collagen Membrane Post-Tooth Extraction: A 6-Month Randomized Controlled Clinical Trial. Int J Periodontics Restorative Dent. 2017 Sep/Oct;37(5):e290-e296. doi: 10.11607/prd.2474.

    PubMed 28817143

Questions about this trial

What is this clinical trial studying?

A study testing bone marrow aspiration from maxillary tuberosity and BMMNCs separation to be seeded on PRF and used for socket preservation in people with Decayed Teeth, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed I Yassin (002 01063718668, ahmedyassin2167@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bucco-palatal width of the alveolar socket after extraction with millimeter by cone-beam computed tomography (CBCT) (time frame: 3 months after extraction and socket preservation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05465421, which also lists 16 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in